MedRx Co., Ltd
Tokyo Stock Exchange 4586.T
MedRx Co., Ltd Share Price on January 14, 2025: USD 0.52
-
MedRx Co., Ltd 52-week high Share Price is USD 0.80 on August 28, 2024, which is 54.67% above the current Share Price.
-
MedRx Co., Ltd 52-week low Share Price is USD 0.49 on December 25, 2024, which is -5.60% below the current Share Price.
-
MedRx Co., Ltd average Share Price for the last 52 weeks is USD 0.63.
| Date | Share Price | Price to Earnings Ratio (P/E) | Price to Sales Ratio (P/S) | Price to Book Ratio (P/B) |
|---|
| CEO | Mr. Yonehiro Matsumura |
| IPO Date | Feb. 14, 2013 |
| Location | Japan |
| Headquarters | 431-7 Nishiyama |
| Employees | 22 |
| Sector | Health Care |
| Industries | |
MedRx Co., Ltd, a pharmaceutical formulation development company, provides pharmaceutical drugs based on the transdermal absorption system in Japan. The company develops medicines based on Ionic liquid transdermal system (ILTS) and Nano-sized Colloid Transdermal System (NCTS); and researches and develops painless transdermal administration system for vaccines, nucleic acid medicines, protein medicines, etc. Its products pipeline includes MRX-4TZT, which is in phase I clinical trials for the treatment of spastic paralysis; MRX-9FLT that is in phase I clinical trials to treat chronic, cancer, and severe pain; and MRX-7MLL and MRX-6LDT that is in pre-clinical trials to treat Alzheimer's disease and chronic pain, as well as MRX-5LBT that has completed the clinical trials for the treatment of postherpetic nerve pain. MedRx Co., Ltd was incorporated in 2002 and is headquartered in Higashikagawa, Japan.
Past 5 years
StockViz Staff
January 15, 2025
Any question? Send us an email